Add to my selection

DOPTELET (avatrombopag)

Medicine - Posted on Sep 30 2021

Active substance (DCI)

avatrombopag

history (2)

9/8/21

DOPTELET 20 mg (avatrombopag)

Key points Unfavourable opinion for reimbursement in the treatment of primary chronic immune thrombocytopenia (ITP) in adult...

CAV :
54321

icône flèche
1/20/21

DOPTELET (avatrombopag)

Key points Unfavourable opinion for reimbursement in the treatment of severe thrombocytopenia in adult patients with chronic...

CAV :
54321

icône flèche

Technical information

ATC code

B02BX08

Manufacturer

SWEDISH ORPHAN BIOVITRUM

Presentation

DOPTELET 20 mg, comprimé pelliculé
Boite de 10 comprimés (CIP : 34009 302 094 6 2)
Boite de 15 comprimés (CIP : 34009 302 094 7 9)

All our publications

Blood and lymphatic diseases

Blood and lymphatic diseases - miscellaneous